Related Experiment Video
Updated: Jan 8, 2026

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.8K
Peanut Inhalant Challenge in Peanut-Allergic Children and Adolescents
Bente Krane Kvenshagen1, Espen Kolsrud2, Martin Sørensen3
1BestHelse Nordstrand, Oslo, Norway.
International Archives of Allergy and Immunology
|December 11, 2025
Summary
Airborne peanut exposure poses a low risk for allergic reactions in children and adolescents. This study found few objective reactions during a peanut inhalation challenge, offering reassurance for proximity to peanuts.
Area of Science:
- Allergy and Immunology
- Pediatric Allergy
- Environmental Exposure
Background:
- Uncertainty exists regarding allergic reactions from airborne peanut exposure.
- Previous small studies suggest a low risk, necessitating further investigation.
- This study addresses the need for more evidence on peanut allergy risks.
Purpose of the Study:
- To assess the risk of allergic reactions during a standardized peanut inhalation challenge.
- To evaluate reactions in a large cohort of children and adolescents with peanut allergy.
- To provide data on the safety of proximity to peanuts.
Main Methods:
- Recruited 323 children/adolescents (5-18 years) with probable peanut allergy.
- Conducted a standardized open peanut inhalation challenge followed by observation.
- Classified allergic responses as subjective or objective, monitoring spirometry and physical exams.
Main Results:
- 15.5% experienced possible allergic reactions; only 3.1% had objective reactions.
- A low incidence of medical treatment (1.2%) and no severe adverse events or hospitalizations occurred.
- The study demonstrated a low risk of significant allergic reactions from airborne peanut exposure.
Conclusions:
- Airborne peanut exposure presents a low risk of significant allergic reactions.
- Findings suggest safety for individuals with peanut allergy in proximity to peanut consumption.
- Reassurance is provided to patients, caregivers, and healthcare professionals.
Related Concept Videos
Allergic Reactions
31.9K
Overview
31.9K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Inhaled Medications
687
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
687
Pulmonary Function Tests
711
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
711
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K

